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Autophagy mediates the degradation of cellular components in lysosomes, assuring removal of altered or
dysfunctional proteins and organelles. Autophagy is not only activated in response to cellular damage; in
fact, one of its strongest and better-characterized stimuli is starvation. Activation of autophagy when
nutrients are scarce allows cells to reutilize their own constituents for energy. Besides protein breakdown,
autophagy also contributes to the mobilization of diverse cellular energy stores. This recently discovered
interplay between autophagy and lipid and carbohydrate metabolism reveals the existence of a dynamic
feedback between autophagy and cellular energy balance.Introduction
Autophagy, or thedegradationof intracellular components in lyso-
somes, has received considerable renewed attention in recent
years. Although originally described in the late 1960s, the first
genes and protein products that contribute to autophagy were
not identified until almost 30 years later (Mizushima et al., 2008).
The discovery of the autophagic molecular machinery has been
rapidly followed by numerous studies supporting the occurrence
of autophagic alterations in different common human disorders
such as cancer, neurodegenerative and muscular diseases, and
infectious disorders, among others (Mehrpour et al., 2010;
Mizushima et al., 2008). Most of these connections of autophagy
with cellular physiology and disease have emphasized the impor-
tant function of autophagy in quality control and clearance of
altered and damaged intracellular proteins and organelles, its
contribution to cellular remodeling through degradation of struc-
tural components, or its role in cellular defense as part of both
the innate and acquired immunity (Mizushima et al., 2008).
This interest in the autophagic process has also recently led to
a renewed attention to the interplay between autophagy and
cellular metabolism. Interestingly, protein catabolism was the
first defined function for autophagy, and the regulation of the
autophagic activity by changes in the nutritional status consti-
tuted the center of attention of many early studies (Mortimore
and Po¨so¨, 1987). The recently gained knowledge about the
molecular components of autophagy has allowed revisiting
under a new light the ‘‘old’’ function of autophagy in cellular
metabolism. In this work, we describe the recent advances on
the contribution of autophagy to cellular fueling through mobili-
zation of distinct intracellular energy stores. We also comment
on the consequences of failure of autophagy on cellular ener-
getic balance and on recently established connections between
compromised autophagy and different metabolic disorders.
Autophagic Pathways and Molecular Effectors
of the Autophagic Process
Recent studies have revealed the existence of multiple mecha-
nisms for the delivery of cargo to lysosomes, which give rise tothe different types of autophagy (Figure 1). Cargo can be seques-
tered selectively or ‘‘in bulk’’ inside de novo formed double
membrane vesicles (or autophagosomes) that acquire the hydro-
lases required for degradation upon fusion with late endosomal
and lysosomal compartments. This form of autophagy, known
as macroautophagy, also includes very different variants de-
pending on whether the cargo is sequestered ‘‘in bulk’’ (cytosol
with any content present in that area) or selectively (mitophagy,
ribophagy, lipophagy, aggregophagy, etc.) (Kadandale and
Kiger, 2010). Sequestration inside vesicles is also the mecha-
nism used for cargo delivery through another type of autophagy
known as microautophagy (Marzella et al., 1981) (Figure 1).
However, in this case the carrier vesicles are single membraned
and originate by invagination of themembrane of lysosomes that
then pinch off inside the lumen where they are rapidly degraded
by the resident hydrolases. In addition to these types of vesicle-
mediated autophagy, single cytosolic proteins can also be
delivered to lysosomes for degradation through chaperone-
mediated autophagy (CMA) (Arias and Cuervo, 2010). In this
type of autophagy, proteins are recognized by a chaperone
complex in the cytosol and delivered one by one to the lysosomal
membrane where they undergo internalization into the lumen
through a membrane translocation complex (Figure 1). In this
review, we focus primarily on macroautophagy because it is
the pathway for which stronger connections to cellular metabo-
lism have been established.
The recent detailed analysis of the molecular components that
participate inmacroautophagy has identifiedmore than 30 genes
and their corresponding proteins (autophagy-related proteins or
Atg) (Mizushima et al., 2008). Atgs organize into functional
complexes that participate in each of the steps of macroautoph-
agy. Readers are referred to recent comprehensive reviews
detailing the intricacies of the macroautophagic machinery and
its contribution to each of the different steps in this process
(Mizushima et al., 2008). Briefly, the first event of macroautoph-
agy is the formation of the nucleation complex, the structure that
will give rise to the limiting membrane of the autophagosome.
ER, mitochondria, Golgi, and plasma membrane have all beenCell Metabolism 13, May 4, 2011 ª2011 Elsevier Inc. 495
Figure 1. Molecular Components of
Mammalian Autophagic Pathways
Scheme of three different types of autophagy co-
existing in mammals. (1) Macroautophagy: A
limiting membrane forms de novo engulfing
cytosolic components and seals to form an
autophagosome. Degradation occurs when auto-
phagosomes fuse with lysosomes. Initiation of
macroautophagy requires assembly and activa-
tion of the lipid kinase complex, class III PI3K that
serves to recruit components of the two conjuga-
tion cascades, the LC3/PE and Atg5/12 cascades
to the limiting membrane. (2) Chaperone-medi-
ated autophagy (CMA): When a cytosolic chap-
erone (hsc70) recognizes a targeting motif
(KFERQ) in cytosolic proteins and delivers them to
the lysosomal membrane. Upon binding to the
lysosome-associated protein type 2A, substrate
proteins unfold and cross the lysosomal
membrane assisted by a lumenal chaperone. (3)
Microautophagy: Invaginations at the lysosomal
membrane trap cytosolic cargo that is internalized
after the vesicles pinch off into the lysosomal
lumen. AA: amino acids; FA: free fatty acids; Atg:
autophagy-related protein; PE: phosphatidyleth-
anolamine.
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viewed in Cuervo, 2010). The common feature in all these sites
of autophagosome formation is the transient association of
a kinase complex formed by vps34, beclin, and vps15 and
different modulatory proteins to the organelle membrane
(Figure 1). The kinase activity of this complex along with the
dynamic delivery of lipids to the site of formation by continuous
shuttling of Atg9, the only transmembrane Atg, generates the
isolation membrane. This membrane elongates to sequester
the cargo through the action of two ubiquitin-like conjugation
systems, modulated by Atg7, that result in the formation of the
Atg5/12 complex and the conjugation of LC3 to phosphatidyleth-
anolamine (Mizushima et al., 1998) (Figure 1). The limiting
membrane eventually seals, confining the cargo inside a double
membrane vesicle that docks and fuses with secondary lyso-
somes and endosomes through mechanisms still only partially
understood. The infusion of hydrolases, and the acidification of
the autophagosome lumen by the proton pump provided by
lysosomes results in the complete degradation of cargo into their
constituent components that then gain access to the cytosol
through permeases at the lysosomal membrane. Formation of
the autophagosomes occurs randomly during nonselective in-
bulk macroautophagy, but it is fit to surround specific cargo
during selective macroautophagy. In the latter case, cargo-
recognizing proteins, such as p62 or NBR1 (Lamark et al.,
2009), act as bridges between the cargo and the autophagic
machinery.
Different signaling mechanisms modulate autophagic activity
in mammalian cells (Mehrpour et al., 2010). The best-character-
ized modulators of macroautophagy are those that regulate this
catabolic pathway in response to nutritional changes, such as
themammalian target of rapamycin (mTOR). This nutrient sensor
kinase complex acts as a hub for the integration of information on
the cellular energetic balance and negatively regulates the initia-496 Cell Metabolism 13, May 4, 2011 ª2011 Elsevier Inc.tion step of macroautophagy. The mechanisms and essential
components of mTOR regulation of macroautophagy will be
described in the following sections. Activation of macroautoph-
agy occurs not only in response to nutritional changes but also
as a consequence of intracellular accumulation of toxic protein
products, organelle damage, infectious agents, and changes in
the physical properties of the extracellular media (Mehrpour
et al., 2010). Although, some of these stressors activate macro-
autophagy bymodulatingmTOR signaling, macroautophagy can
also be activated by mechanisms independent of mTOR (Sarkar
et al., 2009). Current efforts are focused on discriminating the
differences betweenmTOR-dependent andmTOR-independent
macroautophagy and the possible functional interaction
between these two regulatory mechanisms.
Activation of Autophagy in Response to Nutrient
Deprivation
Starvation was recognized as one of the best stimuli of macroau-
tophagy from the very early days, when most studies were done
in rodent liver analyzing differences in the size of the autophagic
compartment (Mortimore and Po¨so¨, 1987). These analyses
unveiled a marked inhibitory effect of insulin on hepatic macro-
autophagy and an opposing stimulatory effect for glucagon
(Mortimore and Po¨so¨, 1987). When yeast was adapted as
a good experimental model to decipher the genetic components
involved in macroautophagy, removal of the source of nutrients
(nitrogen or carbon) was also found to be a universal stimulus
of macroautophagy. In fact, in yeast not only starvation but just
a shift in the carbon source is enough to activate macroautoph-
agy. Depletion of amino acids or serum from the culture media,
or of glucose to a less extent, activates macroautophagy in
mammalian cells in culture (Mitchener et al., 1976).
More recent studies, using a transgenicmousemodel express-
ing a fluorescent marker of macroautophagy, have revealed
Figure 2. Nutritional Regulation of
Macroautophagy
(Top) Under normal nutritional conditions mTOR
(1) phosphorylates ULK1, which locks the ULK1-
ATG13-FIP200 complex at the TORC1 complex
and prevents its interaction with AMPK; and (2)
inactivates DAP1 by phosphorylation. (Bottom)
During starvation, AMPK phosphorylates ULK1
favoring its release from TORC1 and its associa-
tion to the site of isolation membrane formation.
Reduced mTOR activity decreases DAP1 phos-
phorylation that through its inhibitory effect on
macroautophagy prevents abnormal upregulation
of this pathway. The positive-feedback loops
between AMPK, sestrins, and p53 are shown.
Independent of its transcriptional activity, cyto-
solic p53 can exert a direct inhibitory effect on
macroautophagy.
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in heart, skeletalmuscle, exocrineglands, and kidney (Mizushima
et al., 2004). The fact that autophagosomes, the morphological
signature of macroautophagy, were not detected in brain under
these conditions, led to the initial conclusion that macroautoph-
agywas not activated in response to starvation in central nervous
system and even questioned the occurrence of autophagy as
a whole in brain. Subsequent studies have revealed that macro-
autophagy can be markedly upregulated pharmacologically in
brain (Sarkar et al., 2009). In fact, macroautophagy occurs in
neurons and is essential for maintenance of cellular homeostasis
(Hara et al., 2006; Komatsu et al., 2006); however, the rapid clear-
ance of autophagosomes limits the number of them visible at
a given time (Boland et al., 2008).
An interesting example of extreme starvation that requires
proper activation of macroautophagy is the period from birthCell Metabolismuntil newborns gain access to maternal
milk (Kuma et al., 2004). Mice with
compromised macroautophagy are
unable to survive this period, reinforcing
the important role of macroautophagy
as a source of both amino acids and
energy. However, activation of macroau-
tophagy is not limited to extreme nutri-
tional conditions. In fact, in organs such
as liver, this process gets activated daily
in between meals, contributing both to
provide essential components under
these conditions and also guaranteeing
periodical cellular clearance (Mizushima
et al., 2004).
Information on the energy status within
a cell is transduced by signaling path-
ways to effector molecules that promote
growth or activate catabolic pathways,
such as autophagy. As mentioned in the
previous section, mTOR complex 1
(mTORC1) is a critical nutrient sensor
intricately linked to macroautophagic
regulation (Figure 2). In yeast, activation
of TORC hyperphosphorylates Atg13,
preventing its interaction with Atg1(Kamada et al., 2000). The Atg1-Atg13 complex is required to
initiate shuttling of Atg9 to the site of autophagosome formation.
Although the mammalian downstream targets of mTOR required
to regulate macroautophagy remained elusive for long time,
recent studies have revealed that mTORC1 phosphorylates
and actively sequesters the mammalian homolog of Atg1,
ULK1 in a complex with Atg13 and FIP200 in an inactive state
(Chan et al., 2009; Hosokawa et al., 2009; Jung et al., 2009). Acti-
vation of a second cellular energy sensor, AMP-activated protein
kinase (AMPK), during nutrient deprivation inhibits mTOR
activity, reducing ULK1 phosphorylation and promoting its
release from mTORC1 (Egan et al., 2011; Kim et al., 2011;
Lee et al., 2010b; Shang et al., 2011). AMPK-mediated phos-
phorylation of ULK1 at a different residue favors its mobilization
to the region of autophagosome formation and the initiation of
macroautophagy (Kim et al., 2011) (Figure 2). AMPK can also13, May 4, 2011 ª2011 Elsevier Inc. 497
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phosphorylation of the Tuberous sclerosis complex 2 (TSC2) and
Raptor (Gwinn et al., 2008).
Recent studies support the existence of feedback mecha-
nisms that prevent both prolonged activation and sustained
repression of macroautophagy. The death-associated protein
1 (DAP1) is a negative regulator of macroautophagy that remains
inactive through phosphorylation by mTOR. When mTOR is
inhibited, for example during starvation, DAP1 is dephosphory-
lated and contributes to prevent uncontrolled activation of
macroautophagy (Koren et al., 2010). In contrast, cells bypass
the inhibitory effect of chronic mTOR activation on macroau-
tophagy by upregulating a family of proteins known as sestrins.
In addition to sending inhibitory feedback signals to mTOR,
sestrins activate AMPK directly leading to the subsequent upre-
gulation of macroautophagy (Lee et al., 2010a). Likewise, the
phosphorylation of the insulin receptor substrate 1 (IRS1) by
a substrate of mTOR—p70S6K—reduces insulin signaling and
allows induction of macroautophagy even in the presence of
nutrients to sustain its quality-control function.
The number of intracellular signaling pathways with modula-
tory effects on macroautophagy keeps growing, unveiling the
complexity of the regulation of this catabolic process (Mehrpour
et al., 2010). Of particular interest are the connections between
macroautophagy and p53, a tumor suppressor recently shown
to also contribute to regulate energy metabolism (Vousden and
Ryan, 2009). During metabolic stress, p53 is directly activated
by AMPK-dependent phosphorylation, and sestrins and AMPK
are among the many genes activated by p53 (Figure 2). The
effect of p53 on autophagy has revealed to be more complex
than initially anticipated. Thus, p53 mediates the transcriptional
upregulation of autophagy activators such as DRAM (damage-
regulated autophagy modulator) (Crighton et al., 2006) but at
the same time cytosolic forms of p53 can directly repress
autophagy by mechanisms still poorly characterized (Tasdemir
et al., 2008) (Figure 2). Different stress-activated kinases also
link the cellular energy status with macroautophagy. Starva-
tion-induced c-jun N-terminal kinase (JNK) activation leads to
Bcl-2 phosphorylation that makes Beclin-1 accessible for mac-
roautophagic activation (Wei et al., 2008). A noncanonical
MEK/ERK cascade downstream of AMPK and the p38a MAPK
have also both shown to upregulate macroautophagy (Wang
et al., 2009; Webber and Tooze, 2010). Recent studies support
that another cellular stress-activated kinase, IkB kinase (IKK)
modulates nutrient-regulated macroautophagy in a NF-kB-inde-
pendent manner by activating AMPK and JNK1 (Criollo et al.,
2010). Inhibition of macroautophagy by extracellular cytokines
and growth factors is also exerted by multiple signaling
cascades, such as MAPK-ERK1/2, Stat3, Akt/Foxo3, and
CXCR4/GPCR, supporting that tight regulation is responsible
for fine tuning of induction of macroautophagy.
Autophagy in Protein Catabolism
Although lysosomes contain a broad array of hydrolases
(lipases, proteases, glycosidases, nucleotidases) that allows
them to degrade all kind of macromolecules, most of the func-
tional studies on autophagy have focused on protein breakdown.
In fact, for a long time, changes in the rate of degradation of long-
lived proteins were used to monitor autophagy. In liver, autoph-498 Cell Metabolism 13, May 4, 2011 ª2011 Elsevier Inc.agy was estimated to degrade from 1.5% to 5% of the total
proteome per hour under fed or starved conditions, respectively
(Deter et al., 1967). Autophagy was thus responsible for up to
70% of intracellular protein breakdown in this organ, which
was later confirmed in mouse models knocked out for essential
autophagy genes in liver (Komatsu et al., 2005).
Thereare twopurposes for proteinbreakdowns: to utilize amino
acids for cellular fueling and to replenish the intracellular pool of
amino acids required to maintain protein synthesis. In fact, bulk-
protein synthesis has been shown to be substantially reduced in
autophagy-deficient cellular and animal models (Onodera and
Ohsumi, 2005). Although amino acids are in general a poor source
of energy, the fact that different phenotypes due to impairedmac-
roautophagy could be restored by addition of the cell-permeable
tricarboxylic acid-cycle substrate methylpyruvate, supports that
one of the functions of autophagy is to contribute energy (Lum
et al., 2005). However, this fact may need to be revisited in light
of the recently discovered ability of macroautophagy to mobilize
other types of energy stores (discussed in the following sections).
Branched-chain and some dispensable amino acids can be
catabolized in peripheral tissues, and in fact neonates with
compromised macroautophagy showed marked reduction of
these particular amino acids in circulating blood and peripheral
tissues when compared to controls (Kuma et al., 2004). However,
when the energetic requirements of the autophagic process itself
are taken into consideration, the final energy balance would be
rather poor if energy were only to be obtained from the amino
acids generated from protein breakdown. All autophagy variants
require ATP in different steps of the process. Macroautophagy
requires ATP for initiation and progression (Schellens et al.,
1988). In the case of CMA, binding of the chaperones to the
substrates and their unfolding before lysosomal translocation
are also ATP-dependent processes (Arias and Cuervo, 2010).
Similarly, the formation of the membrane invaginations that
sequester cargo for microautophagy drives on ATP hydrolysis
(Sahu et al., 2011). Common to all these pathways is also the
need for ATP to maintain lysosomal pH (Van Dyke, 1988).
In addition to energy, amino acids can be utilized early in fast-
ing to provide substrates for gluconeogenesis and ketogenesis
(in liver) and to replenish the intracellular pool of amino acids
(Figure 3). The contribution of different proteolytic systems to
this replenishment seems to be timed with the duration of the
starvation process. Studies in cultured cells have shown that
the proteasome system contributes most of the amino acids to
this pool in the first hours of starvation (Vabulas and Hartl,
2005), whereas macroautophagy starts right after and reaches
a peak at about 6–8 hr into the starvation period (Deter et al.,
1967). In fact, although autophagosomes are still visible up to
24 hr of starvation, the maximal rates of autophagosome forma-
tion are reached around 6 hr and decline progressively after that.
If starvation persists beyond 8 hr, protein breakdown switches
now to CMA that reaches maximal upregulation at 10–12 hr
into starvation and persists at similar rates up to 3 days (Cuervo
et al., 1995). It is likely that switching from macroautophagy to
CMA may allow cells to spare from degradation essential
proteins and organelles under prolonged nutritional stress.
Although the molecular mechanisms that regulate this autopha-
gic switch are not fully understood, ketone bodies produced
during starvation have been shown to have a stimulatory effect
Figure 3. Different Catabolic Pathways
Converge in Lysosomes
Macroautophagy contributes to the delivery of
proteins, lipid stores, and glycogen for breakdown
into lysosomes. The constituent components of
these macromolecules exit the lysosome and
become available for production of energy. In the
case of protein breakdown, the resulting amino
acids may have less energetic value and be pref-
erentially utilized for the synthesis of new proteins.
Levels of amino acids, free fatty acids, and sugars
circulating in blood or in the extracellular media
have a direct impact on intracellular macro-
autophagy.
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proteins, common substrates for this autophagic pathway (Finn
and Dice, 2005).
As described in previous sections, protein breakdown by
autophagy is self-regulated, as the products of this breakdown,
theconstitutive aminoacids of thecargoproteins, imposeabreak
on the autophagic process. Signaling mechanisms known to
modulate macroautophagy integrate information on both the
availability of extracellular amino acids as well as their levels in
the intracellular pool (Mehrpour et al., 2010). The exact mecha-
nismbywhichamino acids signal throughmTOR todownregulate
macroautophagy is still unclear, but the contribution of vps34,
Ras-related small GTPases (that relocatemTOR to the lysosomal
compartment), and a bidirectional transporter that exchanges
L-glutamine by essential amino acids have all been involved in
this signaling process (Nicklin et al., 2009; Sancak et al., 2010).
Although beyond the scope of this review, degradation of
proteins by autophagy also contributes to quality control and
prevents proteotoxicity associated with accumulation of
abnormal proteins. In fact, defective autophagy often associates
with formation of proteins aggregates (Hara et al., 2006;
Komatsu et al., 2006) and is likely the basis for protein conforma-
tional disorders such as Alzheimer’s and Parkinson’s disease.
Autophagy in Lipid Metabolism
The contribution of autophagy to lipid metabolism has been
recently elucidated through the initial discovery of a process
now termed macrolipophagy (Figure 3) (Singh et al., 2009a).
Mobilization of neutral lipids from lipid droplets (LD; main cellular
lipid stores) to generate fatty acids for mitochondrial oxidationCell Metabolismand energy production or for extracellular
secretion was solely attributed to cyto-
solic or ER-associated lipases. Although
lysosomal lipases (acid lipases) were
considered to only break down endocy-
tosed lipids, we have recently shown
that intracellular lipids can also reach
the lysosomal lumen through sequestra-
tion inside autophagosomes (Singh
et al., 2009a). Pharmacological or genetic
inhibition of macroautophagy in cultured
hepatocytes does not affect lipogenesis
or lipid secretion but leads to reduced
rates of b-oxidation and marked lipid
accumulation in cytosolic LD (Singhet al., 2009a). In fact, mice knocked out for an essential autoph-
agy gene in liver (Atg7) display massive accumulation of triglyc-
erides and cholesterol in the form of LD, confirming that macro-
autophagy is also important for lipolysis in vivo (Singh et al.,
2009a). Although further studies are needed to better elucidate
the mechanisms behind LD recognition and sequestration by
the macroautophagic machinery, preliminary evidence supports
that the limiting membrane of the autophagosome forms at the
surface of the LD trapping only a discrete region of the droplet.
It is possible that specific adaptor proteins may facilitate interac-
tions between lipid droplets and the autophagic components.
Macrolipophagy is not limited to hepatocytes but occurs in
almost every cell type investigated till date. In addition to the
initial description in cultured hepatocytes and embryonic fibro-
blasts (Singh et al., 2009a), disruption of macroautophagy leads
to intracellular accumulation of lipid stores in endothelial cells,
lymphoblasts, dendritic cells, glial cells, and even in neurons
(Koga et al., 2010), suggesting a generalized function of macro-
autophagy in cellular lipid mobilization. The accumulation of LD
upon blockingmacroautophagy even in the absence of any nutri-
tional challenge, supports that macrolipophagy is a constitutive
process in many cells (Singh et al., 2009a) (Figure 4).
Energetically, massive intracellular lipid mobilization may be
particularly advantageous during nutrient deprivation. In fact,
macrolipophagy is activated by starvation and persists beyond
the 6–8 hr limit established for macroautophagy-dependent
proteolysis (Singh et al., 2009a). Prolonged starvation results in
a switch in the type of cytosolic cargo sequestered by
autophagy from a heterogenous mix of cytosolic substrates
toward predominant lipid sequestration at later times (Singh13, May 4, 2011 ª2011 Elsevier Inc. 499
Figure 4. Autophagy in the Metabolism of
Cellular Lipid Stores
(A) Autophagy constitutively mobilizes cellular lipid
droplets by macrolipophagy. Lipid droplets are
sequestered inside autophagosomes and deliv-
ered to the lysosomes for degradation, resulting in
free fatty acid release for cellular respiration.
(B) During acute lipid challenge most cells maxi-
mally activate macrolipophagy to prevent exces-
sive cellular lipid accumulation.
(C) Chronically maintained lipid challenges reduce
macroautophagic degradation of lipids by
decreasing the efficiency of autophagosome-
lysosomal fusion, leading to further cellular lipid
accumulation.
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getically demanding conditions, this process is also used by
different cells to handle massive affluence of lipids (Figure 4).
Exposure of cells to acute lipid challenges upregulates macroli-
pophagy to limit cellular lipid droplet load. However, the stimula-
tory effect of lipids on macroautophagy is not linear and an
exposure of cultured cells to large amounts of lipids or chronic
high-fat feeding in rodents decreases both macrolipophagy
(Singh et al., 2009a) and the macroautophagy of proteins and
organelles (Koga et al., 2010). Maturation of autophagosomes
into autophagolysosomes appears to be affected by this high-
lipid content, likely because of reduced vesicular fusion (Figure 4)
(Koga et al., 2010). In vivo, this defective autophagosome-lyso-
some fusion is partially compensated by fusion of autophago-
somes with endosomes (to form amphisomes), which prevents
massive accumulation of undegraded vesicles yet results in
lower net autophagic balance. Reduced macrolipophagy in
a setting of chronic lipid loading promotes cellular lipid accumu-
lation that may set up a vicious circle resulting in inhibition of
macroautophagy and exaggerated lipid accumulation that may
form the basis for development of fatty liver disease (Figure 4).
The interplay between autophagy and lipid metabolism has
different layers of complexity. Thus, while autophagy serves to
regulate cellular lipid droplets, multiple evidences support an
important modulatory role of lipids and lipid modifications on
autophagy. Lipids, such as phosphatidylinositol 3-phosphate
(PI3P), serve as a scaffold for the assembly of the autophagic
apparatus required for limitingmembrane formation, autophago-
some trafficking in microtubules, lysosomal fusion, and possibly500 Cell Metabolism 13, May 4, 2011 ª2011 Elsevier Inc.even in cargo recognition (reviewed in
Kaushik et al., 2010). A coordinated
balance between the activity of kinases
and phosphatases modulates intracel-
lular levels of PI3P (Vergne et al., 2009).
In addition to regulatory lipid mole-
cules, changes in the content of structural
lipids in the membrane of the organelles
involved in autophagy also affect auto-
phagic activity. For example, the
compromise in autophagosome-lyso-
some fusion in animals exposed to
a high-fat diet is reproducible in vitro by
simply modulating the cholesterol
content of any of the vesicular compart-ments involved in this process (Koga et al., 2010). Changes in
lipid composition of lysosomal and late endosomal membranes
also affect other forms of autophagy such as CMA (Kaushik
et al., 2006) and microautophagy (Sahu et al., 2011).
The function of macroautophagy in the adipose tissue, an
organ committed to fat storage, deserves separate mention,
since autophagy has been shown to regulate adipose tissue
development by modulating adipocyte differentiation (Singh
et al., 2009b; Zhang et al., 2009). Compromised macroautoph-
agy in preadipocytes alters adipocyte differentiation that associ-
ates with decreased levels of adipogenic transcription factors
and markers of adipocyte differentiation (Singh et al., 2009b).
Interestingly, mice deficient in macroautophagy in the white
adipose tissue (knockout for Atg7) show decreased adipose
mass that phenocopies brown adipose tissue (Singh et al.,
2009b; Zhang et al., 2009). The physiological consequence of
this phenotypic switching is a remarkably lean mouse with
improved glucose tolerance (Singh et al., 2009b; Zhang et al.,
2009). While the molecular mechanisms behind macroautoph-
agy-mediated adipocyte differentiation are unclear, it is possible
that accumulation of proteins that modulate adipogenesis or
confer a ‘‘browning’’ effect could be behind abnormal adipose
differentiation. Although the role of macroautophagy in lipid-
droplet biogenesis has only been analyzed in adipose tissue, it
is possible that formation of lipid droplets in other tissues also
requires an intact autophagic system. In support of this idea,
reduced content of lipid droplets has been reported in the livers
of very young mice knocked out for the essential macroautoph-
agy gene Atg7 (Shibata et al., 2009), which contrasts with the
Cell Metabolism
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mouse model as the mice reach adulthood (Singh et al., 2009a).
Autophagy in Carbohydrate Homeostasis
Glycogen degradation by phosphorylase and debranching
enzymes occurs primarily in the cytosol, but lysosomal acid
glycosidases also contribute to glycogen breakdown (Schworer
et al., 1979) (Figure 3). The acute nutrient deprivation that follows
the postnatal period triggers the autophagy of glycogen in liver to
provide glucose (Kalamidas and Kotoulas, 2000). Lysosomal
mannose 6- and glucose-6-phosphatases modulate the phos-
phorylation state of glucose favoring its exit from the lysosome.
Glycophagy is not limited to liver, and in fact, altered autophagic
degradation of glycogen stores may underlie the basis of
different muscle disorders, now classified as autophagic vacu-
olar myopathies, such as Danon disease, X-linked vacuolar
myopathy with excessive autophagy, and Pompe disease
(Fukuda et al., 2007; Nishino et al., 2000). Glycogen granules
accumulate in muscles of Danon disease patients, resulting in
cardiomyopathy, proximal muscle weakness, and mental retar-
dation (Nishino et al., 2000). Distinctive of this disease is the
fact that despite the accumulation of glycogen, levels of acid
maltase activity are normal. Recent studies have revealed that
the primary defect is in the ability to deliver the material seques-
tered in autophagosomes, including glycogen, to lysosomes for
degradation (Nishino et al., 2000). Defective autophagy seems
also behind the accumulation of polyglucosans, poorly branched
glycogen bodies, in organs from patients with Lafora disease
(Aguado et al., 2010). In contrast, glycogen accumulates within
lysosomes in skeletal muscles in Pompe’s disease patients
(Glycogen Storage Disease Type II) due to deficiency of the
lysosomal enzyme acid a-glucosidase that degrades glycogen
(Fukuda et al., 2007). The fact that the primary defect in Pompe
disease is not in the delivery of glycogen to lysosomes bymacro-
autophagy but in degradation once in this compartment explains
the beneficial effects observed upon muscle-specific inhibition
of autophagy (decreased muscle glycogen by half) (Raben
et al., 2010). Althoughmacroautophagy has been so far the focus
of most studies, it is possible that other forms of autophagy, in
particular microautophagy, may also contribute to the delivery
of glycogen granules to the lysosomes (Raben et al., 2010).
Autophagy can indirectly contribute to glucose metabolism by
modulating pancreatic b-cell mass and function (Ebato et al.,
2008; Jung et al., 2008). Mice with b-cell-specific inhibition of
macroautophagy reveal progressive b-cell degeneration and
decreased insulin secretion (Ebato et al., 2008). Although many
factors could contribute to this reduced insulin secretion in mac-
roautophagy-deficient pancreatic b cell, the fact that secretion is
restored upon antioxidant treatment supports that accumulation
of dysfunctional mitochondria that generate reactive oxygen
species could be behind impaired secretion.
Regulation of insulin secretion by controlled lysosomal degra-
dation of insulin secretory granuleswasproposed long ago under
the term ‘‘crinophagy’’ that refers to the direct fusion of secretory
granules with lysosomes (Marzella et al., 1981). However, recent
studies support that macroautophagy can also contribute to the
delivery of these secretory granules to lysosomes. For example,
in the secretory-deficient Rab3/ b cell, intracellular insulin
stores are maintained despite decreased secretion because ofincreased autophagic degradation of insulin (Marsh et al.,
2007). Interestingly, macroautophagy-mediated degradation of
other secretory granules, such as those containing zymogen in
pancreatic acinar cells, may contribute to the activation of the
inactive enzymes in lysosomes. In fact, abnormal upregulation
of macroautophagy with enhanced processing of these lytic
enzymes could be the pathogenic basis for acute pancreatitis
(Grasso et al., 2009; Hashimoto et al., 2008).
Despite the pronounced phenotype of autophagy blockage in
b cells, macroautophagy does not increase in these cells during
starvation (Ebato et al., 2008). Interestingly, active autophago-
some formation was observed in diet-induced obese mice and
in the genetic insulin-resistant db/db mice (Fujitani et al., 2009),
suggesting that impaired insulin signaling permits upregulation
of b-cell autophagy. Increased b-cell macroautophagy in
response to chronic lipid stress is perceived as an adaptive
response against insulin resistance since b-cell expansion that
occurs in response to high-fat feeding is not observed in
b-cell-macroautophagy-deficient mice (Ebato et al., 2008).
The interplay between autophagy and carbohydrate metabo-
lism is also bidirectional as growing evidence supports the regu-
latory effect of different glycidic groups on macroautophagy
(Ravikumar et al., 2003). Both glucose deprivation and increased
cellular glucose affluence have been shown to enhance macro-
autophagy, although likely by different mechanisms (Figure 3).
Activation of macroautophagy during glucose deprivation has
been proposed to be, in part, a consequence of the associated
induction of oxidative stress. In contrast, the enhanced degrada-
tion of pathogenic proteins by macroautophagy elicited by
increasing intracellular glucose was proposed to result from
reduced phosphorylation of Akt, mTOR, and S6K1 mediated
by glucose 6-phosphate, as the effects were mimicked by 2-de-
oxyglucose but not 3-O-methyl glucose that cannot be
phosphorylated (Ravikumar et al., 2003). Other sugars, such as
the disaccharide trehalose, physiologically present in many
nonmammalian species, also induce macroautophagy and
clearance of pathogenic proteins (Sarkar et al., 2007). Although
some of the benefits of trehalose are probably via its chap-
erone-like chemical properties, trehalose can also activate
macroautophagy in an mTOR-independent manner to remove
neurotoxic proteins. Aminosugars such as glucosamine can
also activate macroautophagy for clearing ubiquitin-conjugated
protein aggregates (Shintani et al., 2010).
Metabolic Dysfunction and Autophagy
Defective autophagy has a negative impact in cell metabolism at
very different levels, and in fact recent studies support that it may
be an aggravating factor or even underlie the basis of common
metabolic disorders.
In almost all tissues, the most direct manifestation of the
inability to degrade proteins by autophagy is the accumulation
of polyubiquitinated protein inclusions that can become a sink
for chaperones and proteases, and an additional source of
reactive species (Hara et al., 2006; Komatsu et al., 2006;
Komatsu et al., 2005). In contrast to this well-characterized func-
tion in quality control, there is only sparse information (mainly
restricted to the studies in neonates [Kuma et al., 2004]) on the
metabolic consequences of deficient protein breakdown by
macroautophagy.Cell Metabolism 13, May 4, 2011 ª2011 Elsevier Inc. 501
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between dysfunctional autophagy and lipid and carbohydrate
metabolic disorders, although the autophagic changes are
revealing themselves to be clearly tissue dependent. Exciting
data fromhumanstudies reportedalterations inmacroautophagy
within adipose tissues from obese individuals (Kovsan et al.,
2011). Increased macroautophagy markers and faster
autophagic clearance have been observed in both subcutaneous
fat depots and, to a larger extent, omental fat. Autophagyupregu-
lation is even more pronounced in obese individuals that have
developed insulin resistance (Kovsan et al., 2011). In contrast to
this upregulation of autophagy in adipose tissue and pancreatic
b-cells during adiposity, chronic high-fat feeding inhibits autoph-
agy in liver (Singh et al., 2009a; Yang et al., 2010). In fact, dietary
and genetic models of obesity (ob/ob mouse) display markedly
reduced macroautophagy in liver that alters insulin signaling in
these models (Yang et al., 2010). Proper insulin signaling can
be restored when the autophagic defect is corrected (Yang
et al., 2010). Factors independent of insulin levels per se, likely
ER stress, may contribute to reduced hepatic macroautophagy
in obesity because streptozotocin injections in ob/obmice failed
to restore autophagy in the liver, as opposed to the induction of
autophagy in streptozotocin-injected lean mice (Yang et al.,
2010). Additional mechanisms such as the chronic upregulation
of mTOR signaling observed in obesity (Newgard et al., 2009)
may contribute to decreased macroautophagy. It is plausible
that reduced hepatic macroautophagy during obesity may set
up a vicious circle that furthers insulin resistance secondary to
alterations in proteins crucial for insulin signal transduction.
A similar ‘‘autophagy-related vicious circle’’ may contribute to
the metabolic syndrome and explain its higher prevalence with
age. It is anticipated that the well-documented decrease in mac-
roautophagy activity in liver with age (Cuervo, 2008) will reduce
the ability of this organ to mobilize intracellular lipids and
contribute, at least in part, to altered lipid metabolism (adiposity
and dyslipidemia) intrinsic to the metabolic syndrome. Chemical
manipulation of macroautophagy presents as an attractive anti-
aging therapy that could prevent or delay onset of the metabolic
syndrome. In fact, although selective enhancers of macroau-
tophagy are still missing, several multiaction drugs that
efficiently increase life span in vertebrates and health span in
rodents and primates such as rapamycin, resveratrol, or spermi-
dine (reviewed in Cuervo, 2008; Kaushik et al., 2010) also exert
a stimulatory effect on macroautophagy.
Inhibition of autophagy aimed at reducing cell-intrinsic energy
supply may also have therapeutic applicability as a means to
promote death in cancer cells. Although the interplay between
autophagy and carcinogenesis is highly complex, blockage of
macroautophagy has been shown to reduce tumorigenesis of
cancer cells that upregulate this catabolic pathway to support
the demanding energetic requirements of oncogenesis (readers
interested in this topic are encouraged to consult recent reviews
on this topic [Rabinowitz and White, 2010]).
Concluding Remarks
The multiplicity of mechanisms by which autophagy impacts the
cellular energetic balance reveal that this catabolic pathway is an
important regulator of energy homeostasis. The efficiency of the
system ultimately resides in the confining of a wide array of502 Cell Metabolism 13, May 4, 2011 ª2011 Elsevier Inc.hydrolases in a single compartment with recycling capabilities
and the development of efficient mechanisms for selective
delivery of cargo to this degradative compartment. There are
many aspects of this selectivity that still remain elusive. What
is the signal that triggers glycogen recognition by the autophagy
machinery? What activates the autophagy machinery already
associated to LD to initiate the formation of the sequestering
membrane in macrolipophagy? Even the identification of the
cargo-recognition molecules is still in its early days.
Now that it is accepted that autophagy can contribute to the
mobilization of diverse energy stores, understanding the regula-
tion of each of these processes, the feedback mechanisms from
other catabolic pathways, and the organ-intrinsic differences in
these processes are a priority. Continuous cross-communica-
tion between organs such as the adipose tissue and the liver,
as well as opposing metabolic responses to the same stimulus,
are well characterized; however, the discovery of the role that
differences in autophagy regulators or effectors play in this organ
individuality is just beginning.
Although most efforts and experimental models have evolved
around starvation as a stimulus for autophagy, many other nutri-
tional challenges can affect this catabolic process, and probably
its lipolytic, proteolytic, and glycolytic capabilities are going to be
affected in a different manner depending on the stimuli. As the
number of human pathologies for which alterations in autophagy
are being revealed keeps growing, it will become important to
keep in mind that defective autophagy does not only associate
with accumulation of damaged cellular structures but could
also lead to severe energetic compromise in cells and organs.
In this respect, restoration of normal autophagic activity pres-
ents now as an attractive therapeutic approach for different
pathologies. Most chemical blockers and upregulators of
autophagy used to date do not have the required specificity
and often target major regulatory nodes that affect multiple intra-
cellular pathways. This need for chemical modulators of autoph-
agy is the driving force for more than a dozen currently ongoing
drug screenings that should offer a collection of autophagy-
specific inhibitors and activators in the coming years.ACKNOWLEDGMENTS
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